HyClone ADCF-MAb Media is a regulatory-friendly media developed through Metabolic Pathway Design to increase the process yields for the manufacture of antibodies and antibody fragments for therapeutic use in a variety of engineered hybridoma and recombinant myeloma cell lines.
ADCF-MAb Media contains L-glutamine and Pluronic F68 and does not contain phenol red. It is also available without L-glutamine to support the GS gene expression system.
Highlights:
Animal derived component-free formulation
Metabolically designed for high cell yield and monoclonal antibody production
Allows for direct or sequential adaptation
Component traceability
Manufactured under cGMP
Contains L-glutamine and Pluronic F68
Formulations without L-glutamine support the GS gene expression system